Thalidomide in patients with cachexia due to terminal cancer: Preliminary report

Annals of Oncology

Volumn 10, Issue 7, 1999, Pages 857-859

  Bruera, E ^a,b   Neumann, C M ^a   Pituskin, E ^a   Calder, K ^a   Ball, G ^a   Hanson, J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b GREY NUNS COMMUNITY HOSPITAL   (Canada)

Author keywords

Appetite; Cachexia; Cancer; Thalidomide

Indexed keywords

MEGESTROL ACETATE; THALIDOMIDE;

ADVANCED CANCER; APPETITE; ARTICLE; CACHEXIA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DROWSINESS; DRUG EFFICACY; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SELF REPORT; TREATMENT OUTCOME; VERTIGO; WELLBEING;

EID: 0032771855     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008329821941     Document Type: Article

References (12)

1. Neuenschwander H, Bruera E. Asthenia-Cachexia. In Bruera E, Higginson I (eds): Cachexia-Anorexia in Cancer Patients. Oxford: Oxford University Press 1996; 4: 57-75.
2. Billingsley KG, Alexander HR. The pathophysiology of cachexia in advanced cancer and AIDS. In Bruera E, Higginson I (eds): Cachexia Anorexia in Cancer Patients. Oxford: Oxford University Press 1996; 1-22.
3. Tavares JL, Wangoo A, Dilworth P et al. Thalidomide reduces tumor necrosis factor-alpha production by human alveolar macrophages. Respir Med 1997; 91: 31-9.
4. Tramontana JM, Utaipat U, Molloy A et al. Thalidomide treatment reduces tumor necrosis factor-α production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1995; 1: 384-97.
5. Reyes-Teran G, Sierra-Madero V, Martinez del Cerro H et al. Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double blind, placebo-controlled clinical trial. AIDS 1996; 10: 1501-7.
6. Haslett P, Hempslead M, Seidman C et al. The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with human immunodeficiency virus. AIDS Res Hum Retrovir 1997; 13: 1047-54.
7. Crum RM, Anthony JC, Bassett SS, Holstein MF. Population-based norms for the mini-mental state examination by age and educational level. JAMA 1993; 269: 2386-91.
8. Bruera E, Ernst S, Hagen N et al. Effectiveness of megestrol acetate in patients with advanced cancer: A randomized, double-blind, crossover study. Can Prev Contr 1998; 2: 74-8.
9. Jakeman P,Smith WCS. Thalidomide in leprosy reaction. Lancet 1994; 343: 432-3.
10. Tseng S, Pak G, Washenik K et al. Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol 1996; 35: 969-79.
11. Bruera E, Roca E, Cedaro L et al. Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 1985; 69: 751-4.
12. Bruera E, Fainsinger R, Spachynski K et al. Clinical efficacy of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: A randomized evaluation. J Clin Oncol 1995; 13: 1520-7.